Aura Biosciences Inc(AURA)
$7.61-0.04 (-0.52%)
AURA
Aura Biosciences Inc financials statements
$7.61
At close:-0.04 (-0.52%)
Want to see AURA full AI Analyst Report?
Aura Biosciences Inc (AURA) Ratios
329 Followers
Aura Biosciences Inc Ratios
AURA's free cash flow for Q3 2026 was $-27.22M. For the 2026 fiscal year, AURA's free cash flow was decreased by $-80.00K and operating cash flow was $-27.14M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.15 | 10.77 | 18.76 | 18.81 | 20.90 |
| Quick Ratio | 8.15 | 10.77 | 18.76 | 18.81 | 20.90 |
| Cash Ratio | 3.24 | 2.13 | 3.32 | 11.63 | 20.27 |
| Solvency Ratio | -3.23 | -2.81 | -2.57 | -2.03 | -4.46 |
| Operating Cash Flow Ratio | -4.61 | -5.35 | -5.17 | -5.22 | -4.41 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 117.22M | $ 130.09M | $ 202.57M | $ 168.35M | $ 145.99M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.10 | 0.10 | 0.08 | 0.09 | 0.01 |
| Debt-to-Equity Ratio | 0.13 | 0.12 | 0.09 | 0.11 | 0.01 |
| Debt-to-Capital Ratio | 0.11 | 0.11 | 0.08 | 0.10 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.24 | 1.20 | 1.13 | 1.14 | 1.05 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -2647.62 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -2711.54 |
| Debt to Market Cap | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.29 | 0.38 | 0.49 | 0.70 | 0.03 |
| Net Debt to EBITDA | 0.40 | 0.15 | 0.26 | 1.70 | 4.30 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.10% | 100.13% | 100.18% | 100.00% | 100.00% |
| EBT Per EBIT | 94.05% | 90.31% | 89.74% | 97.46% | 100.00% |
| Return on Assets (ROA) | -62.68% | -47.63% | -29.96% | -26.24% | -22.03% |
| Return on Equity (ROE) | -77.56% | -57.19% | -33.83% | -30.05% | -23.14% |
| Return on Capital Employed (ROCE) | -74.67% | -57.35% | -35.02% | -28.24% | -23.09% |
| Return on Invested Capital (ROIC) | -73.10% | -56.29% | -34.63% | -27.86% | -23.00% |
| Return on Tangible Assets | -62.68% | -47.63% | -29.96% | -26.24% | -22.03% |
| Earnings Yield | -32.29% | -21.30% | -21.77% | -18.69% | -7.11% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.72 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -503.67 | 0.00 | 0.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 503.67 | 0.00 | 0.00 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1.40 | -1.61 | -1.61 | -1.82 | -1.11 |
| Free Cash Flow Per Share | -1.41 | -1.63 | -1.63 | -1.86 | -1.18 |
| Dividend Paid and CapEx Coverage Ratio | -189.58 | -63.69 | -90.05 | -49.91 | -15.25 |
| Capital Expenditure Coverage Ratio | -189.58 | -63.69 | -90.05 | -49.91 | -15.25 |
| Operating Cash Flow Coverage Ratio | -4.88 | -4.25 | -3.26 | -2.62 | -33.24 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -25.91% | -19.86% | -18.39% | -17.72% | -6.96% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -3.10 | -4.70 | -4.59 | -5.35 | -14.07 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.40 | 2.69 | 1.55 | 1.61 | 3.26 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -3.86 | -5.03 | -5.44 | -5.64 | -14.36 |
| Price-to-Operating Cash Flow Ratio | -3.88 | -5.11 | -5.50 | -5.76 | -15.30 |
| Price-to-Earnings Growth (PEG) Ratio | -5.42 | 0.50 | 3.00 | -0.22 | -0.26 |
| Enterprise Value Multiple | -2.73 | -4.62 | -3.94 | -3.61 | -10.11 |
| Enterprise Value | 286.70M | 395.20M | 329.53M | 213.62M | 347.93M |
| EV to EBITDA | -2.73 | -4.62 | -3.94 | -3.61 | -10.11 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -3.37 | -4.88 | -5.10 | -3.84 | -10.07 |
| EV to Operating Cash Flow | -3.38 | -4.95 | -5.16 | -3.91 | -10.74 |
| Tangible Book Value Per Share | 2.27 | 3.06 | 5.70 | 6.53 | 5.21 |
| Shareholders’ Equity Per Share | 2.27 | 3.06 | 5.70 | 6.53 | 5.21 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | -0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -1.76 | -1.75 | -1.93 | -1.96 | -1.21 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 0.90 | 0.97 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.80 | 0.92 | 0.84 | 0.93 | 0.92 |
Currency in USD
